When plasma PCSK9 was >267.60 ng/ml, the risk of developing hypercholesterolemia significantly increased in PNS patients (OR = 6.40, 95% CI 2.06–19.87, p = 0.001). This evidence concerns the gene PCSK9 and paraneoplastic neurologic syndrome.